Search Result "HRD positive"
Durable Disease-free Survival in a Patient with Metastatic Triple-negativeBreast Cancer Treated with Olaparib Monotherapy
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 6 Year: 2022 Page: 530-536
Author(s):
The Mutation and Low Expression of ARID1A are Predictive of a PoorPrognosis and High Immune Infiltration in Triple-negative Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 24 Issue: 1 Year: 2024 Page: 59-68
Author(s):
Challenges of Higher Education Institutions in Assessment Accreditation and Ranking Framework Methodologies
Ebook: Assessment, Accreditation and Ranking Methods for Higher Education Institutes in India: Current Findings and Future Challenges
Volume: 1 Year: 2021
Author(s): K. Sreeramulu
Doi: 10.2174/9781681088174121010004
Structure-activity Relationship Study on Therapeutically Relevant EGFR Double Mutant Inhibitors
Journal: Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2020 Page: 52-62
Author(s): Shehnaz Fatima,Subhash M. Agarwal
PARP Inhibitors in Epithelial Ovarian Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13 Issue: 2 Year: 2018 Page: 145-158
Author(s): Kristin N. Taylor,Ramez N. Eskander
PARP Inhibitors in Ovarian Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13 Issue: 4 Year: 2018 Page: 392-410
Author(s): Gloria Mittica,Eleonora Ghisoni,Gaia Giannone,Sofia Genta,Massimo Aglietta,Anna Sapino,Giorgio Valabrega
Kinase Inhibitors Involved in the Regulation of Autophagy: MolecularConcepts and Clinical Implications
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 13 Year: 2023 Page: 1502-1528
Author(s): Srinivasa Rao Sirasanagandla,Kondaveeti Suresh Babu,Ramakrishna Gopala Sumesh Sofin
BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-Negative Breast Cancer
Journal: Current Drug Targets
Volume: 21 Issue: 10 Year: 2020 Page: 962-973
Author(s): Amal Tazzite,Hassan Jouhadi,Abdellatif Benider,Sellama Nadifi
Nanodiamond Mediated Molecular Targeting in Pancreatic Ductal Adenocarcinoma:Disrupting the Tumor-stromal Cross-talk, Next Hope on theHorizon?
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 8 Year: 2023 Page: 620-633
Author(s): Rajat Subhra Dutta
Chemical IN04 Inhibits the Kinase Domain not the ROC Domain of LRRK1: Results from Homology Modeling and Molecular Docking
Journal: Medicinal Chemistry
Volume: 17 Issue: 10 Year: 2021 Page: 1140-1150
Author(s): Zhenhang Chen,Weirong Xing,Li Fan